{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:43:01Z","timestamp":1785775381551,"version":"3.56.0"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2025-0028_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Vitamin D binding protein (DBP) polymorphism has been linked to parameters related to metabolism, but the problem in hypertensive patients has not been well characterized. The current study sought to characterize the distribution of DBP phenotypes in patients diagnosed with essential hypertension, and evaluate the possible relationships with cardiovascular\u00a0risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2025-0028_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied 411 Caucasian patients with essential hypertension. DBP phenotypes were determined using polyacrylamide gel electrophoresis on serum samples. A review of clinical and laboratory measurements for each patient including blood pressure, serum lipids, and body mass index (BMI), as well as rates of diabetes diagnosis, was conducted and compared across DBP phenotypes. A matched control group (n=141) was utilized for initial comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2025-0028_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DBP phenotype distribution in the study population was consistent with Hardy-Weinberg equilibrium and parallelled the control group. We found no significant differences for systolic and diastolic blood pressure, total cholesterol, HDL, LDL, lipoprotein(a), or other demographic variables, between DBP phenotypes. Unexpectedly, DBP 2-2 phenotype was associated with a significantly higher BMI, and a greater diabetes prevalence in patients, especially in females. Notably, serum triglyceride levels in females classified as DBP 2-2 were also significantly elevated suggesting the possible metabolic consequences are gender specific.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2025-0028_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      DBP 2-2 phenotype appears to be linked to adverse metabolic features in hypertensive patients, particularly among women. These findings support a potential role for\n                      <jats:italic>DBP<\/jats:italic>\n                      genetic variation as a determinant of obesity and diabetes risk, highlighting the need to consider sex-specific genetic influences in metabolic syndrome risk assessments.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2025-0028","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:23:59Z","timestamp":1751361839000},"page":"133-138","source":"Crossref","is-referenced-by-count":2,"title":["Vitamin D binding protein polymorphism is associated with body weight in females"],"prefix":"10.1515","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5702-6792","authenticated-orcid":false,"given":"Joris R.","family":"Delanghe","sequence":"first","affiliation":[{"name":"Department of Diagnostic Sciences , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Clement","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Sciences , Ghent , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn M.","family":"Speeckaert","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics , Ghent University , Ghent , Belgium"},{"name":"Department of Nephrology , Ghent University Hospital , Ghent , Belgium"},{"name":"Research Foundation-Flanders (FWO) , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Duprez","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Department of Medicine, School of Medicine , University of Minnesota , Minneapolis , MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"2025121207242142525_j_hmbci-2025-0028_ref_001","doi-asserted-by":"crossref","unstructured":"Speeckaert, M, Huang, G, Delanghe, JR, Taes, YEC. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006;372:33\u201342. https:\/\/doi.org\/10.1016\/j.cca.2006.03.011.","DOI":"10.1016\/j.cca.2006.03.011"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_002","doi-asserted-by":"crossref","unstructured":"Delanghe, JR, Speeckaert, R, Speeckaert, MM. Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab 2015;29:773\u201386. https:\/\/doi.org\/10.1016\/j.beem.2015.06.006.","DOI":"10.1016\/j.beem.2015.06.006"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_003","doi-asserted-by":"crossref","unstructured":"Speeckaert, MM, Speeckaert, R, Van Geel, N, Delanghe, JR. Vitamin D binding protein. Adv Clin Chem 2014:1\u201357. https:\/\/doi.org\/10.1016\/B978-0-12-800094-6.00001-7.","DOI":"10.1016\/B978-0-12-800094-6.00001-7"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_004","doi-asserted-by":"crossref","unstructured":"Delanghe, JR, Delrue, C, Speeckaert, R, Speeckaert, MM. The potential role of vitamin D binding protein in kidney disease: a comprehensive review. Acta Clin Belg 2024;79:130\u201342. https:\/\/doi.org\/10.1080\/17843286.2023.2301278.","DOI":"10.1080\/17843286.2023.2301278"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_005","doi-asserted-by":"crossref","unstructured":"Cooke, NE, David, EV. Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J\u00a0Clin Investig 1985;76:2420\u20134. https:\/\/doi.org\/10.1172\/JCI112256.","DOI":"10.1172\/JCI112256"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_006","doi-asserted-by":"crossref","unstructured":"Braun, A, Bichlmaier, R, Cleve, H. Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types. Hum Genet 1992;89. https:\/\/doi.org\/10.1007\/BF00194311.","DOI":"10.1007\/BF00194311"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_007","doi-asserted-by":"crossref","unstructured":"White, P, Cooke, N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000;11:320\u20137. https:\/\/doi.org\/10.1016\/S1043-27600000317-9.","DOI":"10.1016\/S1043-2760(00)00317-9"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_008","doi-asserted-by":"crossref","unstructured":"Gasparri, C, Curcio, A, Torella, D, Gaspari, M, Celi, V, Salituri, F, et al.. Proteomics reveals high levels of vitamin D binding protein in myocardial infarction. Front Biosci 2010;2:796\u2013804. https:\/\/doi.org\/10.2741\/e140.","DOI":"10.2741\/e140"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_009","doi-asserted-by":"crossref","unstructured":"Schiller, NB, Shah, PM, Crawford, M, DeMaria, A, Devereux, R, Feigenbaum, H, et al.. Recommendations for Quantitation of the left ventricle by two-dimensional echocardiography. J\u00a0Am Soc Echocardiogr 1989;2:358\u201367. https:\/\/doi.org\/10.1016\/S0894-73178980014-8.","DOI":"10.1016\/S0894-7317(89)80014-8"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_010","unstructured":"World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications\u202f: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999."},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_011","doi-asserted-by":"crossref","unstructured":"Allain, CC, Poon, LS, Chan, CS, Richmond, W, Fu, PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470\u20135. https:\/\/doi.org\/10.1093\/clinchem\/20.4.470.","DOI":"10.1093\/clinchem\/20.4.470"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_012","doi-asserted-by":"crossref","unstructured":"Bucolo, G, David, H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476\u201382. https:\/\/doi.org\/10.1093\/clinchem\/19.5.476.","DOI":"10.1093\/clinchem\/19.5.476"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_013","doi-asserted-by":"crossref","unstructured":"Nauck, M, M\u00e4rz, W, Jarausch, J, Cobbaert, C, S\u00e4gers, A, Bernard, D, et al.. Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment. Clin Chem 1997;43:1622\u20139.","DOI":"10.1093\/clinchem\/43.9.1622"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_014","doi-asserted-by":"crossref","unstructured":"Friedewald, WT, Levy, RI, Fredrickson, DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499\u2013502. https:\/\/doi.org\/10.1093\/clinchem\/18.6.499.","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_015","doi-asserted-by":"crossref","unstructured":"Schmidt, HH-J, Genschel, JC, Wagner, S, Manns, MP. Quantification of lipoprotein(a): comparison of an automated latex-enhanced nephelometric assay with an immunoenzymometric method. Eur Clin Chem Lab Med 1996;34:119\u201324. https:\/\/doi.org\/10.1515\/cclm.1996.34.2.119.","DOI":"10.1515\/cclm.1996.34.2.119"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_016","unstructured":"Parker, WC, Cleve, H, Bearn, AG. Determination of phenotypes in the human group-specific component (Gc) system by starch gel electrophoresis. Am J Hum Genet 1963;15:353\u201367."},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_017","doi-asserted-by":"crossref","unstructured":"Rahimi, MH, Mollahosseini, M, Mirzababaei, A, Yekaninejad, MS, Maghbooli, Z, Mirzaei, K. Interactions between vitamin D binding protein variants and major dietary patterns on the odds of metabolic syndrome and its components in apparently healthy adults. Diabetol Metab Syndr 2019;11:28. https:\/\/doi.org\/10.1186\/s13098-019-0422-1.","DOI":"10.1186\/s13098-019-0422-1"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_018","doi-asserted-by":"crossref","unstructured":"Karuwanarint, P, Phonrat, B, Tungtrongchitr, A, Suriyaprom, K, Chuengsamarn, S, Schweigert, FJ, et al.. Vitamin D-binding protein and its polymorphisms as a predictor for metabolic syndrome. Biomarkers Med 2018;12:465\u201373. https:\/\/doi.org\/10.2217\/bmm-2018-0029.","DOI":"10.2217\/bmm-2018-0029"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_019","doi-asserted-by":"crossref","unstructured":"Stroia, CM, Ghitea, TC, Vr\u00e2nceanu, M, Mure\u015fan, M, Bimbo-Szuhai, E, Pallag, CR, et al.. Relationship between Vitamin D3 deficiency, metabolic syndrome and VDR, GC, and CYP2R1 gene polymorphisms. Nutrients 2024;16:1272. https:\/\/doi.org\/10.3390\/nu16091272.","DOI":"10.3390\/nu16091272"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_020","doi-asserted-by":"crossref","unstructured":"Santos, BR, Lecke, SB, Spritzer, PM. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: a cross-sectional study. PLoS One 2017;12:e0173695. https:\/\/doi.org\/10.1371\/journal.pone.0173695.","DOI":"10.1371\/journal.pone.0173695"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_021","doi-asserted-by":"crossref","unstructured":"Wang, G, Li, Y, Li, L, Yu, F, Cui, L, Ba, Y, et al.. Association of the vitamin D binding protein polymorphisms with the risk of type 2 diabetes mellitus: a meta-analysis. BMJ Open 2014;4:e005617. https:\/\/doi.org\/10.1136\/bmjopen-2014-005617.","DOI":"10.1136\/bmjopen-2014-005617"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_022","doi-asserted-by":"crossref","unstructured":"Afzal, S, Bojesen, SE, Nordestgaard, BG. Low 25-hydroxyvitamin D and risk of type 2 Diabetes: a prospective cohort study and metaanalysis. Clin Chem 2013;59:381\u201391. https:\/\/doi.org\/10.1373\/clinchem.2012.193003.","DOI":"10.1373\/clinchem.2012.193003"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_023","doi-asserted-by":"crossref","unstructured":"Bikle, DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 2014;21:319\u201329. https:\/\/doi.org\/10.1016\/j.chembiol.2013.12.016.","DOI":"10.1016\/j.chembiol.2013.12.016"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_024","doi-asserted-by":"crossref","unstructured":"Lauridsen, AL, Vestergaard, P, Hermann, AP, Brot, C, Heickendorff, L, Mosekilde, L, et al.. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 2005;77:15\u201322. https:\/\/doi.org\/10.1007\/s00223-004-0227-5.","DOI":"10.1007\/s00223-004-0227-5"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_025","doi-asserted-by":"crossref","unstructured":"Speeckaert, MM, Glorieux, GL, Vanholder, R, Van Biesen, W, Taes, YE, Clement, F, et al.. Vitamin D binding protein and the need for vitamin D in hemodialysis patients. J\u00a0Ren Nutr 2008;18:400\u20137. https:\/\/doi.org\/10.1053\/j.jrn.2008.04.013.","DOI":"10.1053\/j.jrn.2008.04.013"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_026","doi-asserted-by":"crossref","unstructured":"Ashraf, AP, Huisingh, C, Alvarez, JA, Wang, X, Gower, BA. Insulin resistance indices are inversely associated with vitamin D binding protein concentrations. J\u00a0Clin Endocrinol Metab 2014;99:178\u201383. https:\/\/doi.org\/10.1210\/jc.2013-2452.","DOI":"10.1210\/jc.2013-2452"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_027","doi-asserted-by":"crossref","unstructured":"Delanghe, JR, Speeckaert, MM, Maenhout, T. Factors to take into account when interpreting 25-hydroxy-vitamin D serum levels. Acta Clin Belg 2024;79:97\u2013102. https:\/\/doi.org\/10.1080\/17843286.2024.2327218.","DOI":"10.1080\/17843286.2024.2327218"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_028","doi-asserted-by":"crossref","unstructured":"Wortsman, J, Matsuoka, LY, Chen, TC, Lu, Z, Holick, MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690\u20133. https:\/\/doi.org\/10.1093\/ajcn\/72.3.690.","DOI":"10.1093\/ajcn\/72.3.690"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_029","doi-asserted-by":"crossref","unstructured":"Speeckaert, MM, Taes, YE, De Buyzere, ML, Christophe, AB, Kaufman, J-M, Delanghe, JR. Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann Clin Biochem 2010;47:143\u201350. https:\/\/doi.org\/10.1258\/acb.2009.009018.","DOI":"10.1258\/acb.2009.009018"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_030","doi-asserted-by":"crossref","unstructured":"Fasshauer, M, Bl\u00fcher, M. Adipokines in health and disease. Trends Pharmacol Sci 2015;36:461\u201370. https:\/\/doi.org\/10.1016\/j.tips.2015.04.014.","DOI":"10.1016\/j.tips.2015.04.014"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_031","doi-asserted-by":"crossref","unstructured":"Pop, LC, Shapses, SA, Chang, B, Sun, W, Wang, X. Vitamin D-binding protein in healthy pre- and postmenopausal women: relationship with estradiol concentrations. Endocr Pract 2015;21:936\u201342. https:\/\/doi.org\/10.4158\/EP15623.OR.","DOI":"10.4158\/EP15623.OR"},{"key":"2025121207242142525_j_hmbci-2025-0028_ref_032","doi-asserted-by":"crossref","unstructured":"Yu, S, Wang, Y, Li, X, Mao, Z, Yu, F, Wang, L, et al.. Methylation in 3\u2032 near region of GC gene and its association with the level of vitamin D binding protein and type 2 diabetes mellitus. Nutrition Res 2018;54:52\u20139. https:\/\/doi.org\/10.1016\/j.nutres.2018.03.016.","DOI":"10.1016\/j.nutres.2018.03.016"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0028\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0028\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:24:05Z","timestamp":1765527845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2025-0028\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,11]]},"published-print":{"date-parts":[[2025,9,23]]}},"alternative-id":["10.1515\/hmbci-2025-0028"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2025-0028","relation":{},"ISSN":["1868-1883","1868-1891"],"issn-type":[{"value":"1868-1883","type":"print"},{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}